Scientific Program
09:00 – 10:00
Exhibition & Networking Area (Manhattan 10-13)
REGISTRATION AND REFRESHMENT
10:00 – 12:00
Plenary hall (Manhattan 1-9)
OPENING PLENARY SESSION: SETTING THE STAGE FOR CaReMeLO
Chair: Avraham Karasik, Tel Aviv University, Israel
10:00 – 10:10
WELCOME AND CONFERENCE GOALS
Avraham Karasik, Tel Aviv University, Israel
Agnieszka Mastalerz-Migas, Polish Society of Family Medicine (PTMR), Poland
KEYNOTE LECTURES:
10:10 – 10:30
IS TREATING OBESITY FIRST THE RIGHT APPROACH IN CaReMeLO PATIENTS?
Karolina Kloda, Polish Society of Family Medicine (PTMR), Poland
10:30 – 10:50
CUTTING-EDGE STRATEGIES FOR PREVENTING AND MANAGING CARDIAC DISEASE IN CaReMeLO SYNDROME
Eberhard Standl, Helmholtz Diabetes Centre, Germany
10:50 – 11:10
RENAL RENAISSANCE: TRANSFORMING KIDNEY CARE
Hiddo Heerspink, University Medical Center Groningen, Netherlands
11:10 – 11:30
OVERCOMING PRIMARY CARE CHALLENGES IN MANAGING CaReMeLO PATIENTS
Shlomo Vinker, Tel Aviv University, Israel
11:30 – 11:50
PRE-DIABETES AND CARDIOVASCULAR RISK – WHAT IS NEW?
Brij Mohan Makkar, Diabetes & Obesity Centre, India
11:50 – 12:00
Panel discussion
(12:00 – 12:10) Short technical break
12:10 – 13:10
Plenary hall (Manhattan 1-9)
INDUSTRY SYMPOSIUM
Industry session not included in the main event CME/CPD credit. For more information, please click here.
13:10 – 14:10
Exhibition & Networking Area (Manhattan 10-13)
LUNCH, NETWORKING & ORAL PRESENTATIONS
Chair: Małgorzata Koziarska-Rościszewska, Medical University of Lodz, Poland
13:20-13:28
THE DEVELOPMENT AND IMPLEMENTATION OF AN INTEGRATED MULTI-MORBIDITY MODEL OF CARDIOVASCULAR-RENAL (KIDNEY)-METABOLIC CARE IN LONDON, UK
Ciara A. Doherty, Guys and St Thomas NHS Foundation trust, United Kingdom
13:28-13:36
THE ROLE OF INTEGRATED MULTI-SPECIALIST PHARMACISTS IN THE DELIVERY OF A MULTI-MORBIDITY CARDIOVASCULAR-RENAL (KIDNEY)-METABOLIC MODEL OF CARE IN LONDON, UK
Jaskiran Sanghera, Kings College Hospital NHS trust, United Kingdom
13:36-13:44
SOCIAL ATTITUDES, FAMILY SUPPORT, AND SELF-STIGMA IN ADULT POLISH WOMEN USING ANTI-OBESITY MEDICATIONS
Tomasz Witaszek, Indywidualna Praktyka Lekarska, Poland
13:44-13:52
STRATEGIES TO IMPROVE THERAPEUTIC COMPLIANCE OF CAREMELO PATIENTS
Justyna Tymińska, Lazarski University, Poland
13:52-14:00
USING THE CONSTRAINED-DISORDER-PRINCIPLE-BASED SECOND-GENERATION ARTIFICIAL INTELLIGENCE SYSTEM FOR IMPROVING THE RESPONSE TO THERAPIES FOR CARDIOMETABOLIC DISORDERS
Yaron Ilan, Hebrew University Hadassah Medical Center, Israel
14:00-14:08
PREVALENCE AND IMPACT OF COMORBIDITIES IN PRIMARY SJÖGREN’S SYNDROME: A RETROSPECTIVE STUDY
Ana Guida Araujo Freitas, USF Beira Saúde, Portugal
14:10 – 15:40
Plenary hall (Manhattan 1-9)
SESSION 1: REAL-WORLD CASE STUDIES AND EXPERT INSIGHTS
Moderator: Baruch Itzhak, Clalit Health Services, Israel
Case Discussions:
14:10 – 14:30
Asymptomatic Patients with Diabetes
Josep Vilaseca, University of Vic – University of Central Catalonia, Spain
14:30 – 14:50
Patient with HFpEF
Jan Biegus, Wroclaw Medical University, Poland
14:50 – 15:10
Patient with Renal Involvement
Mateusz Szmidt, Medical University of Białystok, Poland
15:10 – 15:30
Patient with Obesity, Diabetes and Atrial Fibrillation
Alina Kuryłowicz, Center of Postgraduate Medical Education, Poland
15:30 -15:40
Panel discussion
15:40 – 16:10
Exhibition & Networking Area (Manhattan 10-13)
COFFEE BREAK AND NETWORKING
15:55 – 16:05
Shape the Future of Care: Join UNLOKall: Multidisciplinary Academy
Catarina Morais, UNLOK, Portugal
16:10 – 17:10
Plenary hall (Manhattan 1-9)
INDUSTRY SYMPOSIUM
Industry session not included in the main event CME/CPD credit. For more information, please click here.
(17:10 – 17:20) Short technical break
17:20 – 18:50
Plenary hall (Manhattan 1-9)
TRANSFORMING CaReMeLO CARE: BREAKTHROUGHS FROM 2024 RCTs
Chair: Karolina Kloda, Polish Society of Family Medicine (PTMR), Poland
17:20 – 17:50
EXPANDING THE BOUNDARIES OF THERAPEUTICS: GAME-CHANGING EVIDENCE
Lee Kaplan, Obesity and Metabolism Institute in Boston, USA
17:50 – 18:20
HEART DISEASE IN FOCUS: TRANSFORMING OUTCOMES IN THE CaReMeLO PATIENT
Avraham Karasik, Tel Aviv University, Israel
18:20 – 18:50
Panel Discussion: TURNING EVIDENCE INTO PRACTICE FOR THE CaReMeLO PATIENT
Moderator: Lee Kaplan, Obesity and Metabolism Institute in Boston, USA
Panelists:
Karolina Kłoda, Polish Society of Family Medicine (PTMR), Poland
Mariusz Wyleżoł, Polish Society for Obesity Treatment, Poland
Aleksander Biesiada, Polish Society of Family Medicine (PTMR), Poland
Justyna Ledwoch, Polish Society of Family Medicine (PTMR), Poland
18:50 – 20:00
Exhibition & Networking Area (Manhattan 10-13)
WELCOME RECEPTION, ORAL PRESENTATIONS & NETWORKING
Chairs: Magdalena Bujnowska-Fedak, Wroclaw Medical University, Poland
Małgorzata Koziarska-Rościszewska, Department of Family Medicine – Medical University of Lodz, Poland
19:00-19:08
AN APPLICATION OF URINARY PEPTIDOMICS AND IN SILICO METHODS TO GUIDE MULTIFACTORIAL INTERVENTION IN CHRONIC KIDNEY DISEASE
Agnieszka Latosinska, Mosaiques Diagnostics, Germany
19:08-19:16
TELOMERE LENGTH AS A BIOMARKER IN DIABETIC KIDNEY DISEASE
Yanina Rebrova, D. F. Chebotarev Institute of Gerontology of the National Academy of Medical Sciences, Ukraine
19:16-19:24
TLT-1 AS A POTENTIAL INTERVENTIONAL TARGET IN CARDIOVASCULAR DISEASE
Valance Washington, Oakland University, USA
19:24-19:32
THE DUAL IMPACT OF CHOLESTEROL AND PULSE PRESSURE ON CHRONIC KIDNEY DISEASE OUTCOMES
Suela Mumajesi, Mother Teresa Hospital Tirana, Albania
19:32-19:40
THE ROLE OF SGLT2 INHIBITORS IN THE COMPLEX TREATMENT OF PATIENTS WITH CHRONIC KIDNEY DISEASE – THE RESULTS OF ONE TERTIARY CENTER
Milena K. Nikolova, Clinic of Nephrology, University Hospital, Bulgaria
19:40-19:48
LOW-FREQUENCY ULTRASOUND AS A THERAPEUTIC ENHANCER OF RENIN-ANGIOTENSIN SYSTEM INHIBITOR EFFECTS IN ENDOTHELIAL, RENAL, AND HEPATIC CELLS: FOCUS ON CELLULAR FUNCTION AND INFLAMMATION MARKERS
Ieva Čiapienė, Institute of Cardiology, Lithuanian University of Health Sciences, Lithuania
19:48-19:56
GUT MICROBIOME DYSBIOSIS AND CARDIOVASCULAR-KIDNEY-METABOLIC (CKM) SYNDROME: IS THERE A LINK?
Diana Przeworska, Janusz Korczak Specialist Hospital, Poland
08:30 – 09:30
Plenary hall (Manhattan 1-9)
SESSION 2: LEADING THE CHANGE – FAMILY PHYSICIANS IN CaReMeLO
Chairman: Thomas Frese, Institute of General Practice and Family Medicine, Germany
Best Practices and Innovations:
08:30 – 08:45
ISRAELI EXPERIENCE IN PCP LEADERSHIP
Avraham Karasik, Tel Aviv University, Israel
08:45 – 09:00
PCP ROLE IN CaReMeLO TREATMENT IN POLAND AND CENTRAL EUROPE
Aleksander Biesiada, Polish Society of Family Medicine (PTMR), Poland
09:00 – 09:15
THE SPANISH EXPERIENCE
Josep Vilaseca, University of Vic – University of Central Catalonia, Spain
09:15 – 09:30
THE APPROACH IN THE EMERGINING AND BROAD SCENE IN INDIA
Banshi Saboo, Dia Care to Diabetes Care & Hormone Clinic at Ahmedabad, India
(09:30 – 09:40) Short technical break
09:40 – 10:40
Plenary hall (Manhattan 1-9)
TRANSFORMATIVE TEAM-BASED CARE
Chair: Shlomo Vinker, Tel Aviv University, Israel
09:40 – 09:55
ENHANCING QUALITY OF CARE AND OUTCOMES
Ana Cebrián Cuenca, Murcian Health Service, Spain
09:55 – 10:40
Panel Discussion: EMPOWERING FAMILY PHYSICIANS
Moderators: Michalina Bou-Matar, Polish Society of Family Medicine (PTMR), Poland
Thomas Frese, Institute of General Practice and Family Medicine, Germany
Panelists:
Justyna Ledwoch, Polish Society of Family Medicine (PTMR), Poland
Baruch Itzhak, Clalit Health Services, Israel
Ana Cebrián Cuenca, Murcian Health Service, Spain
10:40 – 11:10
Exhibition & Networking Area (Manhattan 10-13)
COFFEE BREAK AND NETWORKING
11:10 – 12:10
Plenary hall (Manhattan 1-9)
INDUSTRY SYMPOSIUM
Industry session not included in the main event CME/CPD credit. For more information, please click here.
12:10 – 13:30
Exhibition & Networking Area (Manhattan 10-13)
LUNCH AND ORAL PRESENTATIONS
Chair:
Magdalena Bujnowska-Fedak, Wroclaw Medical University, Poland
12:30-12:38
MACHINE LEARNING IDENTIFIES PATTERNS IN MICROBIOME COMPOSITION IN TYPE 2 DIABETES PATIENTS
Dominika Tomczyk, Utrecht University, Netherlands
12:38-12:46
SIGNS OF MYOCARDIAL FIBROSIS IN PATIENTS WITH OBESITY WITHOUT CARDIOVASCULAR DISEASE
Ivanna Zubovych, The Scientific and Practical Medical Center of Pediatric Cardiology and Cardiac Surgery of the Ministry of Health, Ukraine
12:46-12:54
REAL-WORLD DATA FOR TIRZEPATIDE TREATMENT IN TYPE 2 DIABETES MELLITUS (T2DM) TO ADDRESS HBA1C AND OBESITY WITH CONSIDERATION OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE (ASCVD)
Victoria L. Scott, Marsh Medical Practice, United Kingdom
12:54-13:02
REAL WORLD STUDY OF TIRZEPATIDE IN A SECONDARY CARE SPECIALIST DIABETES SERVICE IN THE UNITED KINGDOM (UK)
David T. Otuonye, Ipswich Hospital, East Suffolk and North Essex NHS Foundation Trust, United Kingdom
13:02-13:10
TREATMENT WITH A NOVEL ZINC-SIDEROPHORE COMPLEX MINIMIZES (UP TO COMPLETE ELIMINATION) OF THE INSULIN RESISTANCE IN TYPE 2 DIABETIC ANIMAL MODELS
Mordechai M. Chevion, Hebrew University of Jerusalem, Israel
13:10-13:18
TRAINING PROGRAM FOCUSED AT IMPROVING MUSCULOSKELETAL PAIN AND WEIGHT LOSS IN PATIENTS WITH OBESITY
Carla Romagnolli, University of Sao Paulo, Brazil
13:18-13:26
STRATEGY FOR SCREENING AND MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IN PRIMARY CARE
Ana Guida Araujo Freitas, USF Beira Saúde, Portugal
13:30 – 15:00
Plenary hall (Manhattan 1-9)
THE HEART IN THE MIDDLE OF CaReMeLO
Chairs:
Magdalena Kędziora, Polish Society of Family Medicine (PTMR), Poland
Paweł Balsam, Medical University of Warsaw, Poland
13:30 – 14:30
MASTERING THE BASICS INCLUDING ECHO WORKSHOP
Nir Flint, Tel Aviv Medical Center, Israel
Baruch Itzhak, Clalit Health Services, Israel
14:30 – 15:00
PILLARS OF THERAPY IN HEART FAILURE
Jan Biegus, Wroclaw Medical University, Poland
(15:00 – 15:10) Short technical break
15:10 – 16:10
Plenary hall (Manhattan 1-9)
NAVIGATING LIVER CHALLENGES IN CaReMeLO: INTEGRATING MODERN THERAPIES
Chair: Joanna Szeląg, Polish Society of Family Medicine (PTMR), Poland
15:10 – 15:30
THE LIVER AS THE NEXUS IN CAREMELO PATIENTS
Luisa Vonghia, Antwerp University Hospital, Belgium
15:30 – 15:50
CASE STUDY: A CAREMELO PATIENT WITH MASH AND MULTISYSTEM INVOLVEMENT
Juan Mendive, Catalan Health Institute, Spain
Joanna Szeląg, Polish Society of Family Medicine (PTMR), Poland
15:50 – 16:10
THE CROSSTALK BETWEEN THE PCP AND SPECIALIST IN THE CARE OF MASLD
Luisa Vonghia, Antwerp University Hospital, Belgium
Juan Mendive, Catalan Health Institute, Spain
16:10 – 16:40
Exhibition & Networking Area (Manhattan 10-13)
COFFEE BREAK AND NETWORKING
16:40 – 18:30
Plenary hall (Manhattan 1-9)
INDUSTRY SYMPOSIUM
Industry session not included in the main event CME/CPD credit. For more information, please click here.
(18:30 – 18:40) Short technical break
18:40 – 19:40
Plenary hall (Manhattan 1-9)
THE KIDNEY IN THE MIDDLE OF CaReMeLO
Chair: Per-Henrik Groop, University of Helsinki and Helsinki University Hospital, Finland
18:40 – 19:10
WHY THE KIDNEY IS CENTRAL TO CaReMeLO CARE AND HOW TO APPROACH ITS CARE
David Wheeler, University College London, United Kingdom
19:10 – 19:40
CASE STUDY: MULTIDISCIPLINARY MANAGEMENT OF CKD IN CaReMeLO PATIENTS
David Wheeler, University College London, United Kingdom
Joanna Iskra-Trifunović, AGMED Medical Center Poland
19:40 – 20:00
Plenary hall (Manhattan 1-9)
THE CLOSING SESSION: PATH FORWARD AND KEY TAKEAWAYS
Avraham Karasik, Tel Aviv University, Israel
Baruch Itzhak, Clalit Health Services, Israel
Josep Vilaseca, University of Vic – University of Central Catalonia, Spain
Karolina Kloda, Polish Society of Family Medicine (PTMR), Poland
Aleksander Biesiada, Polish Society of Family Medicine (PTMR), Poland